DexCom Inc’s, the company that makes continuous glucose monitoring (CGM) systems, stock dropped precipitously, by a whopping 40% – from $107.8 to $64 in a single day.
The reason is Bleichmar Fonti & Auld LLP’s investigation into DexCom, Inc for potential violations of the federal securities laws.
You can learn more here, https://www.bfalaw.com/cases-investigations/dexcom-inc.
DexCom Inc (DXCM) Stock Yearly Returns since 2005
